Alfred Maelicke
Plus aucun poste en cours
Profil
Alfred Maelicke was the founder and had founded Galantos Pharma GmbH in 2005, where he held the title of Chief Executive Officer in 2013.
He also held the position of Chief Scientific Officer at Biofrontera AG from 2000 to 2003.
Additionally, he was a Professor & Head-Biochemistry Department at The Johannes Gutenberg University of Mainz from 1989 to 2003.
He was also a Head-Research Unit at Max Planck Gesellschaft zur Förderung der Wissenschaften eV.
Furthermore, he was a Faculty Member at The Rockefeller University and the University of Maryland Medical Center.
He was also a Member-Consecutive Board at Verband der Chemischen Industrie eV.
Anciens postes connus de Alfred Maelicke
| Sociétés | Poste | Fin |
|---|---|---|
| BIOFRONTERA AG | Directeur Technique/Scientifique/R&D | 01/01/2003 |
| The Johannes Gutenberg University of Mainz | Corporate Officer/Principal | 01/01/2003 |
Verband der Chemischen Industrie eV
 Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Corporate Officer/Principal | - |
| University of Maryland Medical Center | Corporate Officer/Principal | - |
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
 Max Planck Gesellschaft zur Förderung der Wissenschaften eV Investment Trusts/Mutual FundsMiscellaneous Max Planck Gesellschaft zur Förderung der Wissenschaften eV (MPG) is a non-profit organization headquartered in Munich, Germany. The firm was founded in 1948 as a successor organization to the Kaiser Wilhelm Society. MPG conducts basic research in the natural sciences, life sciences, and humanities and provides investment advisory services to foundations. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOFRONTERA AG | Health Technology |
| Entreprise privées | 3 |
|---|---|
Max Planck Gesellschaft zur Förderung der Wissenschaften eV
Max Planck Gesellschaft zur Förderung der Wissenschaften eV Investment Trusts/Mutual FundsMiscellaneous Max Planck Gesellschaft zur Förderung der Wissenschaften eV (MPG) is a non-profit organization headquartered in Munich, Germany. The firm was founded in 1948 as a successor organization to the Kaiser Wilhelm Society. MPG conducts basic research in the natural sciences, life sciences, and humanities and provides investment advisory services to foundations. | Miscellaneous |
Galantos Pharma GmbH
 Galantos Pharma GmbH Pharmaceuticals: MajorHealth Technology Galantos Pharma GmbH focuses on the research and development of novel drugs for the treatment of neurodegenerative diseases, in particular Alzheimer's Disease. Its products include memogain, memogain Preclinical, memogain disease-modification, neuroprotective compounds and anti-apoptotic drugs. The company was founded in 2005 by Alfred Maelicke and Ulrich Jordis and is headquartered in Mainz, Germany. | Health Technology |
Verband der Chemischen Industrie eV
Verband der Chemischen Industrie eV Miscellaneous Commercial ServicesCommercial Services Verband der Chemischen Industrie eV operates a chemical industry association. The non-profit company is based in Frankfurt am Main, Germany. | Commercial Services |